Company Filing History:
Years Active: 2013
Title: Daren Stephens: Innovator in Neurological Treatments
Introduction
Daren Stephens is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of neurology through his innovative research and patent work. His focus on phospholipase A2 inhibitors has the potential to transform treatments for neurological injuries and diseases.
Latest Patents
Daren Stephens holds a patent for "Phospholipase A2 inhibitors and their use in treating neurological injury and disease." This patent describes how phospholipase A (PLA) forms are expressed in the spinal cord, and their inhibition can induce potent antihyperalgesia. The patent details compounds that include a common motif consisting of a 2-oxoamide with a hydrocarbon tail and a four-carbon tether. These compounds are designed to block Group IVA calcium-dependent PLA (cPLA), Group VIA calcium-independent PLA (iPLA), and Group V secreted PLA (sPLA). The pharmaceutical compositions derived from these compounds are particularly useful in treating multiple sclerosis and spinal cord injuries, promoting functional recovery.
Career Highlights
Daren Stephens is affiliated with the University of California, where he continues to advance his research in the field of neurology. His work has garnered attention for its potential applications in treating debilitating conditions that affect the nervous system.
Collaborations
Daren has collaborated with esteemed colleagues such as Edward A. Dennis and Samuel David. Their combined expertise enhances the research and development of innovative treatments in neurology.
Conclusion
Daren Stephens is a pioneering inventor whose work on phospholipase A2 inhibitors holds promise for improving the lives of individuals suffering from neurological injuries and diseases. His contributions to the field are invaluable and continue to inspire further research and innovation.